What is Xeris Biopharma Holdings, Inc.'s free cash flow?

Xeris Biopharma Holdings, Inc. (XERS) reported free cash flow of -$29.08M in Q4 2021.

What does free cash flow mean?

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Xeris Biopharma Holdings, Inc. XERS Free cash flow

Discontinued — last reported Q4 '21

Free cash flow at other companies

Eli LillyLLY

$3.01B+1,828%

Eton Pharmaceuticals, Inc.ETON

$7.33M+251%

Ultragenyx PharmaceuticalRARE

-$198M-18.6%

Zevra Therapeutics, Inc.ZVRA

$6.11M+173%

ANI PharmaceuticalsANIP

$52.3M+60.8%

Corcept TherapeuticsCORT

——

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Valuation

See full

Market cap$1.28B+18.3%

Enterprise value$1.42B+8.7%

P/E106.4×—

P/S4.1×-0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.

−$28.9Mnet cash from operating−$131.0Kcapital expenditures=-$29.08M

The official record: Xeris Biopharma Holdings, Inc.’s 10-K, filed March 6, 2024, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s free cash flow?: Xeris Biopharma Holdings, Inc. (XERS) reported free cash flow of -$29.08M in Q4 2021.
What does free cash flow mean?: Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.